Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-11-07 Purchase | 2022-11-09 4:05 pm | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 30,000 | $5.16 | $154,800 | 89,512 (Direct) | View |
2022-03-02 Sale | 2022-03-04 4:13 pm | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 4,849 | $12.01 | $58,236 | 228,798 (Direct) | View |
2021-11-09 Sale | 2021-11-12 4:18 pm | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 150,000 | $30.25 | $4,537,280 | 83,761 (Direct) | View |
2021-11-01 Sale | 2021-11-03 4:20 pm | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 45,000 | $31.64 | $1,423,800 | 176,861 (Direct) | View |
2021-09-20 Sale | 2021-09-22 4:31 pm | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 116,000 | $23.44 | $2,718,725 | 241,261 (Direct) | View |
2021-09-15 Sale | 2021-09-16 5:01 pm | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 44,000 | $21.78 | $958,220 | 212,861 (Direct) | View |
2021-09-13 Sale | 2021-09-14 6:16 pm | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 115,000 | $20.89 | $2,402,217 | 426,861 (Direct) | View |
2021-09-07 Sale | 2021-09-08 4:04 pm | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 7,500 | $18.1 | $135,750 | 176,861 (Direct) | View |
2021-08-26 Sale | 2021-08-27 4:09 pm | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 22,500 | $17.81 | $400,725 | 184,361 (Direct) | View |
2021-08-09 Sale | 2021-08-10 4:09 pm | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 5,000 | $16.01 | $80,050 | 206,861 (Direct) | View |
2021-07-28 Sale | 2021-07-29 4:09 pm | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 5,000 | $13.86 | $69,300 | 211,861 (Direct) | View |
2021-06-22 Sale | 2021-06-23 4:06 pm | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 5,000 | $13.76 | $68,800 | 216,861 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-03-02 Option Award | 2023-03-06 4:28 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 107,202 | $0 | 259,162 (Direct) | View |
2022-03-02 Option Award | 2022-03-04 4:13 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 177,786 | $0 | 228,798 (Direct) | View |
2021-11-11 Exercise | 2021-11-12 4:18 pm | N/A 2030-01-28 | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 29,000 | $0 | 83,761 (Direct) | View |
2021-11-11 Exercise | 2021-11-12 4:18 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 29,000 | $18.38 | 83,761 (Direct) | View |
2021-11-01 Exercise | 2021-11-03 4:20 pm | N/A 2027-02-09 | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 45,000 | $0 | 176,861 (Direct) | View |
2021-11-01 Exercise | 2021-11-03 4:20 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 45,000 | $3.2 | 176,861 (Direct) | View |
2021-09-21 Exercise | 2021-09-22 4:31 pm | N/A 2028-02-01 | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 87,500 | $0 | 241,261 (Direct) | View |
2021-09-21 Exercise | 2021-09-22 4:31 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 10,000 | $18.38 | 241,261 (Direct) | View |
2021-09-20 Exercise | 2021-09-22 4:31 pm | N/A 2028-02-01 | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 36,000 | $5.3 | 241,261 (Direct) | View |
2021-09-21 Exercise | 2021-09-22 4:31 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 70,000 | $6.06 | 241,261 (Direct) | View |
2021-09-14 Exercise | 2021-09-16 5:01 pm | N/A 2028-02-01 | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 44,000 | $0 | 212,861 (Direct) | View |
2021-09-14 Exercise | 2021-09-16 5:01 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 44,000 | $5.3 | 212,861 (Direct) | View |
2021-09-13 Exercise | 2021-09-14 6:16 pm | N/A 2028-02-01 | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 115,000 | $0 | 426,861 (Direct) | View |
2021-09-14 Exercise | 2021-09-14 6:16 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 45,000 | $3.2 | 426,861 (Direct) | View |
2021-09-13 Exercise | 2021-09-14 6:16 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 70,000 | $5.3 | 426,861 (Direct) | View |
2021-05-11 Exercise | 2021-05-12 4:30 pm | N/A 2021-03-30 | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 20,000 | $0 | 221,861 (Direct) | View |
2021-05-11 Exercise | 2021-05-12 4:30 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 20,000 | $3.02 | 221,861 (Direct) | View |
Ownership | 2021-01-04 6:05 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer | 0 | $0 | 681,386 (Direct) | View |